PlainRecalls
FDA Drug Moderate Class II Terminated

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

Reported: June 26, 2019 Initiated: May 6, 2019 #D-1442-2019

Product Description

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

Reason for Recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Details

Units Affected
204 1000-count bottles
Distribution
Nationwide in the USA
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 204 1000-count bottles.
Why was this product recalled?
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 26, 2019. Severity: Moderate. Recall number: D-1442-2019.